ALLURION TECHNOLOGIES, INC. (ALUR) - Dilution Analysis

10-Q filing | 15.0M shares outstanding

10-K filing | 15.0M shares outstanding

S-3 filing: This is an S-3 filing for the registration of resale of common stock by selling securityholders.

POS AM filing: This prospectus relates to the potential offer and sale from time to time by the selling securityholders identified in this prospectus of up to an aggregate of 15,686,056 shares of common stock and also relates to the issuance by us of up to 750,383 shares of common stock issuable upon exercise of public warrants to purchase shares of our common stock.

10-Q filing | 9.3M shares outstanding

10-Q filing | 7.3M shares outstanding

10-Q filing | 7.5M shares outstanding

S-3 filing: This is an S-3 filing for the registration of resale of common stock by selling securityholders and potential proceeds from warrant exercises.

8-K filing: Allurion Technologies issued 1,492,537 shares of common stock to the Purchasers upon conversion of $5 million principal amount of Notes at a price of $3.35 per share due to the triggering of a Market Capitalization Condition. ($5.0M proceeds)

10-K filing | 6.0M shares outstanding

S-1/A filing: The company is filing an S-1/A to offer up to 3,926,701 shares of common stock, Series A common warrants to purchase up to 5,890,051 shares of common stock, Series B common warrants to purchase up to 3,926,701 shares of common stock, and pre-funded warrants to purchase up to 3,926,701 shares of common stock.

S-1/A filing: The company is offering up to 1,918,158 shares of common stock, or pre-funded warrants in lieu thereof, and new warrants to purchase up to an aggregate of 2,877,237 shares of common stock.

POS AM filing: This prospectus relates to the potential offer and sale from time to time by Chardan Capital Markets LLC of up to 9,482,468 shares of our common stock pursuant to a ChEF Purchase Agreement.

S-3/A filing: This S-3/A filing registers an indeterminate amount of common stock, preferred stock, debt securities, warrants and/or units, up to a total value of $100,000,000.

S-1 filing: The filing is an S-1 registration statement for a proposed offering of common stock, pre-funded warrants, and common warrants, with Roth Capital Partners, LLC acting as the exclusive placement agent.

S-3 filing: The company may offer common stock, preferred stock, warrants to purchase shares of common stock or preferred stock, debt securities, subscription rights to purchase shares of common stock, preferred stock or debt securities, and units consisting of any combination of the securities listed above, up to a total dollar amount of $100 million.

10-Q filing | 64.1M shares outstanding

S-1/A filing: This is an S-1/A filing detailing recent sales of unregistered securities, including convertible senior secured notes and Series A Preferred Stock with warrants, in private placement transactions.

S-1/A filing: This S-1/A filing registers for resale up to 65,211,325 shares of common stock by the selling securityholder, including shares issuable upon conversion of convertible notes and preferred stock, and exercise of warrants, without the company receiving any proceeds.

10-Q filing | 64.3M shares outstanding

S-1 filing: This S-1 filing by Allurion Technologies, Inc. details the offering of common stock and warrants to purchase additional shares, with Jefferies LLC and TD Securities (USA) LLC acting as joint book-running managers. RTW has indicated interest to purchase an aggregate of $3.0 million in the offering.

POS AM filing: This prospectus relates to the resale from time to time by the selling securityholders named in this prospectus of up to 37,418,547 shares of our common stock issued or issuable in connection with the business combination between Allurion Technologies, Inc. and Compute Health Acquisition Corp, the resale of up to an aggregate of 369,883 shares of Common Stock issuable upon the exercise of warrants to purchase shares of our Common Stock and the issuance by us of up to 18,759,838 shares of Common Stock issuable upon the exercise of public warrants.

POS AM filing: This prospectus relates to the potential offer and sale from time to time by Chardan Capital Markets LLC of up to 9,482,468 shares of our common stock pursuant to a ChEF Purchase Agreement establishing a committed equity facility.

S-1 filing: This S-1 filing relates to the potential offer and sale of up to 30,191,900 shares of common stock issuable upon the conversion of convertible senior secured notes held by the selling securityholder.

10-Q filing | 47.8M shares outstanding

10-K filing | 47.9M shares outstanding

S-1 filing: This prospectus relates to the potential offer and sale from time to time by Chardan Capital Markets LLC of up to 9,482,468 shares of our common stock.

S-1/A filing: This S-1/A filing relates to the resale of common stock and common stock issuable upon exercise of warrants by selling securityholders, as well as the issuance of common stock upon exercise of public warrants.

S-1/A filing: This S-1/A filing registers for resale (i) up to 37,428,658 shares of common stock by selling securityholders, (ii) 371,935 shares of common stock issuable upon exercise of rollover warrants, and (iii) 18,759,838 shares of common stock issuable upon exercise of public warrants.

10-Q filing | 47.5M shares outstanding

10-Q filing | 46.5M shares outstanding

S-1/A filing: This prospectus relates to the resale from time to time by the selling securityholders of up to 37,300,374 shares of common stock and the issuance by us of up to 18,759,838 shares of Common Stock issuable upon the exercise of public warrants to purchase shares of our Common Stock.

S-1 filing: This S-1 filing relates to the resale of common stock by selling securityholders and the issuance of common stock upon exercise of warrants.